Skip to content

Clinical trials

Phase 1 Stomach Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Country / region: United States Clear all

256 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20018
20024
20034
20045
20051
20065
20076
20082
20091
20106
20114
20127
20134
20149
20159
20168
201714
201811
201921
202017
202116
202219
202313
202410
202519
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed122
Terminated46
Recruiting42
Active, not recruiting27
Unknown status9
Not yet recruiting3
Suspended3
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
AbbVie7
Memorial Sloan Kettering Cancer Center6
M.D. Anderson Cancer Center5
Pfizer5
Seagen Inc.5
Celldex Therapeutics3
City of Hope Medical Center3
Eli Lilly and Company3
Fate Therapeutics3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms256
Breast Neoplasms100
Carcinoma, Non-Small-Cell Lung98
Colorectal Neoplasms96
Esophageal Neoplasms96
Pancreatic Neoplasms86
Ovarian Neoplasms80
Neoplasms59
Squamous Cell Carcinoma of Head and Neck55
Carcinoma, Hepatocellular54

Trials

Showing 1 to 25 of 256. Each trial links to its page on Pharma Observatory.

156 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.